Browsing Tag

Nasdaq:CDNA

CareDx Receives CE Mark for AlloSeq HCT for Use in Hematopoietic Cell Transplantation

Eli Pacheco May 24, 2022 0

SOUTH SAN FRANCISCO, Calif., May 24, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of…

Health

CareDx Demonstrates Potential of AlloHeme and AlloCell for Allogeneic Cell Transplant…

Eli Pacheco Apr 22, 2022 0

SOUTH SAN FRANCISCO, Calif., April 22, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of…

Health

CareDx Reports Over 200,000 Heart Transplant Patient Results Served

Eli Pacheco Apr 15, 2022 0

SOUTH SAN FRANCISCO, Calif., April 14, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of…

Health

CareDx Wins $44.9M in Damages in False Advertising Trial Against Natera; Natera…

Eli Pacheco Mar 15, 2022 0

SOUTH SAN FRANCISCO, Calif., March 14, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and…

Health

CareDx Announces Cibiltech Initiates CIBIL Study Using iBox Artificial Intelligence…

Eli Pacheco Mar 3, 2022 0

SOUTH SAN FRANCISCO, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of…

Health

Landmark ADMIRAL Study Publication with CareDx’s AlloSure Kidney is the First…

Eli Pacheco Jan 12, 2022 0

ADMIRAL Study Shows AlloSure Detects Clinical and Subclinical ABMR and TCMR, and Predicts Long-Term Outcomes for Kidney Transplant Patients AlloSure Showed 62% Improvement Over Standard of…

Health

NIH Study Shows Using CareDx’s AlloSure Lung for Transplant Surveillance is More…

Eli Pacheco Jan 7, 2022 0

SOUTH SAN FRANCISCO, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of…

Health

University of Alabama Integrates CareDx’s TxAccess for Connection to Over 500…

Eli Pacheco Nov 4, 2021 0

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and…

Health

CareDx Extends Leadership in Multimodality Transplant Care with KidneyCare Validation…

Eli Pacheco Oct 1, 2021 0

SOUTH SAN FRANCISCO, Calif., Sept. 30, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine company focused on the discovery, development, and…